2 September 2009
The number of new cancer cases globally will grow by 30% over the next decade, according to a new report from the Economist Intelligence Unit (EIU). By 2020, the number of cases will reach nearly 17 million, an increase of four million on today’s figures. An aging population and the growing prevalence of the disease in the emerging territories are two of the main drivers for the predicted rise. Cancer is already the world’s second biggest killer, claiming more people every year than HIV/AIDS, malaria and tuberculosis combined.
EIU estimates that, with regard to cancer, the price of medical and non-medical costs and lost productivity will total US$286bn in 2009 (an estimation it describes as “conservative”); despite this, only $19bn will be spent on cancer research. The report speculates how much it would cost to achieve a “global funding expenditure standard”, based on achieving per-case spending around the world . It is estimated that achieving this standard, based on 2009 new cancer cases, would require an additional US$217bn.
Commissioned by LIVESTRONG, an initiative of the Lance Armstrong Foundation (LAF), the report, Breakaway: The global burden of cancer - challenges and opportunities, is available free of charge at www.eiu.com/LAF
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.